➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Merck
Johnson and Johnson
Dow
Moodys

Last Updated: October 22, 2020

DrugPatentWatch Database Preview

Details for Patent: 7,931,212

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,931,212
Title:Fluid droplet production apparatus and method
Abstract: A fluid dispersion device comprises a substrate (3) having an outer section (25) and an inner section (26), said inner section (26) of the substrate (3) having an aperture (11), a dispersion element (10) positioned at said aperture (11) of said substrate (3), and an actuator (4) arranged to coaxially surround said aperture (11) of said substrate (3), wherein the outer edge of said inner section (26) of said substrate (3) is coupled to said outer section (25) of said substrate by a plurality of resilient members (81, 82, 83).
Inventor(s): Urich; Markus (Munchen, DE), Hyde; Samuel Charles William (Girton, GB), Pollock; Neil (Royston, GB), Sant; Andrew Jonathan (Fen Ditton, GB)
Assignee: PARI Pharma GmbH (Starnberg, DE)
Application Number:10/522,344
Patent Claim Types:
see list of patent claims
Device;

Drugs Protected by US Patent 7,931,212

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,931,212

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
02016972Aug 2, 2002
PCT Information
PCT FiledJuly 31, 2003PCT Application Number:PCT/EP03/08482
PCT Publication Date:February 19, 2004PCT Publication Number: WO2004/014569

International Family Members for US Patent 7,931,212

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 463304   Start Trial
Germany 60235883   Start Trial
European Patent Office 1386672   Start Trial
World Intellectual Property Organization (WIPO) 2004014569   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
McKinsey
Boehringer Ingelheim
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.